Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Ultralife (ULBI) over the last 14 years, with Q3 2025 value amounting to $16.7 million.

  • Ultralife's Shares Outstanding (Diluted Average) fell 103.71% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year decrease of 103.71%. This contributed to the annual value of $16.8 million for FY2024, which is 333.42% up from last year.
  • As of Q3 2025, Ultralife's Shares Outstanding (Diluted Average) stood at $16.7 million, which was down 103.71% from $16.7 million recorded in Q2 2025.
  • Ultralife's 5-year Shares Outstanding (Diluted Average) high stood at $16.9 million for Q3 2024, and its period low was $16.1 million during Q1 2023.
  • Its 4-year average for Shares Outstanding (Diluted Average) is $16.5 million, with a median of $16.5 million in 2024.
  • In the last 5 years, Ultralife's Shares Outstanding (Diluted Average) surged by 421.83% in 2024 and then tumbled by 103.71% in 2025.
  • Ultralife's Shares Outstanding (Diluted Average) (Quarter) stood at $16.3 million in 2021, then fell by 0.21% to $16.2 million in 2023, then grew by 3.33% to $16.8 million in 2024, then decreased by 0.41% to $16.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $16.7 million in Q3 2025, compared to $16.7 million in Q2 2025 and $16.7 million in Q1 2025.